TTD | Drug: D0T0SK

Drug General Information
Drug ID	D0T0SK
Former ID	DNC009087
Drug Name	ST-2987
Drug Type	Small molecular drug
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Investigative	[530016]
Formula	C17H15N3O5
Canonical SMILES	C1=CC(=CC=C1CON=CC2=CC=C(C=C2)C=CC(=O)NO)[N+](=O)[O-]
InChI	1S/C17H15N3O5/c21-17(19-22)10-7-13-1-3-14(4-2-13)11-18-25-12-15-5-8-16(9-6-15)20(23)24/h1-11,22H,12H2,(H,19,21)/b10-7+,18-11+
InChIKey	IWWFFHDXUHSRDM-PFMZDYLOSA-N
PubChem Compound ID	44138032
Target and Pathway
Target(s)	Histone deacetylase 2	Target Info	Inhibitor	[530016]
	Histone Deacetylase 10	Target Info	Inhibitor	[530016]
	Histone Deacetylase 8	Target Info	Inhibitor	[530016]
	Histone deacetylase 4	Target Info	Inhibitor	[530016]
	Histone deacetylase 6	Target Info	Inhibitor	[530016]
	Histone deacetylase 1	Target Info	Inhibitor	[530016]
	Histone deacetylase	Target Info	Inhibitor	[530016]
KEGG Pathway	Cell cycle
	Notch signaling pathway
	Thyroid hormone signaling pathway
	Huntington's disease
	Alcoholism
	Epstein-Barr virus infection
	Pathways in cancer
	Transcriptional misregulation in cancer
	Viral carcinogenesis
	Chronic myeloid leukemiahsa05034:Alcoholism
	Viral carcinogenesishsa05034:Alcoholism
	MicroRNAs in cancerhsa05034:Alcoholism
	Viral carcinogenesishsa04110:Cell cycle
	Amphetamine addiction
	MicroRNAs in cancer
	Chronic myeloid leukemia
NetPath Pathway	TCR Signaling PathwayNetPath_14:IL2 Signaling PathwayNetPath_11:TCR Signaling Pathway
PANTHER Pathway	Wnt signaling pathwayP00057:Wnt signaling pathwayP00057:Wnt signaling pathway
PANTHER Pathway	p53 pathway
Pathway Interaction Database	Regulation of nuclear SMAD2/3 signaling
	Signaling events mediated by HDAC Class I
	Regulation of Telomerase
	Glucocorticoid receptor regulatory network
	Direct p53 effectors
	Hedgehog signaling events mediated by Gli proteins
	Regulation of nuclear beta catenin signaling and target gene transcriptionhdac_classii_pathway:Signaling events mediated by HDAC Class II
	Signaling events mediated by HDAC Class Ihdac_classi_pathway:Signaling events mediated by HDAC Class Ihdac_classii_pathway:Signaling events mediated by HDAC Class II
	Signaling events mediated by HDAC Class III
	Sumoylation by RanBP2 regulates transcriptional repression
	Validated nuclear estrogen receptor alpha networkhdac_classii_pathway:Signaling events mediated by HDAC Class II
	Signaling events mediated by HDAC Class Ismad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling
	Notch signaling pathway
	E2F transcription factor network
	Presenilin action in Notch and Wnt signaling
	Regulation of Androgen receptor activity
	IL3-mediated signaling events
	Validated nuclear estrogen receptor alpha network
	Retinoic acid receptors-mediated signaling
	Regulation of nuclear beta catenin signaling and target gene transcription
	Validated targets of C-MYC transcriptional repression
	Regulation of retinoblastoma protein
	Notch-mediated HES/HEY network
Reactome	p75NTR negatively regulates cell cycle via SC1
	NOTCH1 Intracellular Domain Regulates Transcription
	Constitutive Signaling by NOTCH1 PEST Domain Mutants
	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
	HDACs deacetylate histones
	NoRC negatively regulates rRNA expression
	RNA Polymerase I Transcription Initiation
	Factors involved in megakaryocyte development and platelet productionR-HSA-2122947:NOTCH1 Intracellular Domain Regulates Transcription
	HDACs deacetylate histonesR-HSA-2122947:NOTCH1 Intracellular Domain Regulates Transcription
	Constitutive Signaling by NOTCH1 HD+PEST Domain MutantsR-HSA-2122947:NOTCH1 Intracellular Domain Regulates Transcription
	Assembly of the primary ciliumR-HSA-1538133:G0 and Early G1
	Formation of the beta-catenin:TCF transactivating complex
	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
	Deactivation of the beta-catenin transactivating complex
	Factors involved in megakaryocyte development and platelet production
WikiPathways	Notch Signaling Pathway
	Notch Signaling Pathway
	Neural Crest Differentiation
	Signalling by NGF
	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
	Factors involved in megakaryocyte development and platelet production
	Cell CycleWP2377:Integrated Pancreatic Cancer Pathway
	Cell CycleWP474:Endochondral Ossification
	Cardiac Hypertrophic Response
	miR-targeted genes in muscle cell - TarBase
	miR-targeted genes in lymphocytes - TarBase
	miR-targeted genes in epithelium - TarBase
	TarBasePathway
	Cell Cycle
	MicroRNAs in cardiomyocyte hypertrophyWP2858:Ectoderm Differentiation
	Cell CycleWP706:SIDS Susceptibility Pathways
	TGF beta Signaling Pathway
	IL-6 signaling pathway
	Apoptosis-related network due to altered Notch3 in ovarian cancer
	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
	Retinoblastoma (RB) in Cancer
	TWEAK Signaling Pathway
	Integrated Breast Cancer Pathway
	Mitotic G1-G1/S phases
	Androgen receptor signaling pathway
References
Ref 530016	Bioorg Med Chem Lett. 2009 Apr 15;19(8):2346-9. Epub 2009 Feb 12.N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC)inhibitors.
Ref 530016	Bioorg Med Chem Lett. 2009 Apr 15;19(8):2346-9. Epub 2009 Feb 12.N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC)inhibitors.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

Drug Information